Finance

Lists
Why is TRDA down ၇.၇၅%?
Dive Deeper
TRDA:NASDAQ
Entrada Therapeutics Inc
၄.၆၄ US$
-၇.၇၅%
(-၀.၃၉) 1D
၄.၆၄ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: နို ၁၉, GMT-၅ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRDA...
Open
၅.၀၂ US$
High
၅.၃၄ US$
Low
၄.၅၉ US$
Mkt. cap
၁၈.၁၇ ကုဋေ
Avg. vol.
၄.၈၉ သိန်း
Volume
၃.၄၁ သိန်း
52-wk high
၁၆.၄၅ US$
52-wk low
၄.၁၁ US$
EPS
-၃.၈၄ US$
Beta
-၀.၁၉
Shares outstanding
၃.၉၂ ကုဋေ
No. of employees
၁၅၂
Open
၅.၀၂ US$
High
၅.၃၄ US$
Low
၄.၅၉ US$
Mkt. cap
၁၈.၁၇ ကုဋေ
Avg. vol.
၄.၈၉ သိန်း
Volume
၃.၄၁ သိန်း
52-wk high
၁၆.၄၅ US$
52-wk low
၄.၁၁ US$
EPS
-၃.၈၄ US$
Beta
-၀.၁၉
Shares outstanding
၃.၉၂ ကုဋေ
No. of employees
၁၅၂
News stories
From web sources and news partners
FOREX.com
FOREX.com
·
ပြီးခဲ့သည့် ၅ နာရီ
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
FXStreet
FXStreet
·
ပြီးခဲ့သည့် ၆ နာရီ
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
Traders Union
·
ပြီးခဲ့သည့် ၆ နာရီ
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
BigGo Finance
BigGo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
About Entrada Therapeutics Inc
CEO-
Employees၁၅၂
Founded၂၀၁၆
Headquartersဘော့စတွန်မြို့, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to TRDA in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for TRDA in the last 3 months.
Highest
Current ၄.၆၄ US$
၂၅.၀၀ US$ (+၄၃၈.၇၉%)
Average
၁၇.၇၅ US$ (+၂၈၂.၅၄%)
Lowest
၁၀.၀၀ US$ (+၁၁၅.၅၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
၁၃.၀၀ US$
+၁၈၀.၂%
11/18/2026
Ram Selvaraju
H.C. Wainwright
Hold
Reiterated
-
-
11/12/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
၁၀.၀၀ US$
+၁၁၅.၅%
11/06/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
11/05/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
၂၅.၀၀ US$
+၄၃၈.၈%
10/15/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
၂၃.၀၀ US$
+၃၉၅.၇%
09/03/2026
Myles Minter
William Blair
Buy
Maintained
-
-
08/05/2026
Yanni Souroutzidis
Cantor Fitzgerald
Buy
Initiated
-
-
04/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၁.၃၀ သန်း
၈.၇၅ သိန်း
၈.၉၈ သိန်း
၉.၀၅ သိန်း
Cost of goods sold
၃.၂၃ ကုဋေ
၃.၃၁ ကုဋေ
၃.၅၄ ကုဋေ
၃.၂၄ ကုဋေ
Cost of revenue
၃.၂၃ ကုဋေ
၃.၃၁ ကုဋေ
၃.၅၄ ကုဋေ
၃.၂၄ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၉.၃၅ သန်း
၁.၀၁ ကုဋေ
၁.၀၅ ကုဋေ
၁.၀၂ ကုဋေ
Operating expense
၉.၃၅ သန်း
၁.၀၁ ကုဋေ
၁.၀၅ ကုဋေ
၁.၀၂ ကုဋေ
Total operating expenses
၄.၁၆ ကုဋေ
၄.၃၂ ကုဋေ
၄.၅၉ ကုဋေ
၄.၂၆ ကုဋေ
Operating income
-၄.၀၃ ကုဋေ
-၄.၂၃ ကုဋေ
-၄.၅၀ ကုဋေ
-၄.၁၇ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၃.၉၁ ကုဋေ
-၃.၉၇ ကုဋေ
-၄.၂၇ ကုဋေ
-၃.၉၇ ကုဋေ
EBT excluding unusual items
-၃.၇၂ ကုဋေ
-၃.၉၇ ကုဋေ
-၄.၂၇ ကုဋေ
-၃.၉၇ ကုဋေ
Income tax expense
၉.၂၀ သောင်း
၃.၈၀ သောင်း
၃.၅၀ သောင်း
၂.၇၀ သောင်း
Effective tax rate
-၀.၂၄%
-၀.၁၀%
-၀.၀၈%
-၀.၀၇%
Other operating expenses
-
-
-
-
Net income
-၃.၉၂ ကုဋေ
-၃.၉၇ ကုဋေ
-၄.၂၈ ကုဋေ
-၃.၉၇ ကုဋေ
Net profit margin
-၃,၀၁၄.၉၃%
-၄,၅၃၉.၀၉%
-၄,၇၆၂.၀၃%
-၄,၃၉၁.၃၈%
Earnings per share
-၀.၉၄
-၀.၉၅
-၁.၀၁
-၀.၉၄
Interest and investment income
၃.၁၄ သန်း
၂.၆၂ သန်း
၂.၂၄ သန်း
၁.၉၇ သန်း
Interest expense
-
-
-
-
Net interest expenses
၃.၁၄ သန်း
၂.၆၂ သန်း
၂.၂၄ သန်း
၁.၉၇ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၃.၉၄ ကုဋေ
-၄.၁၅ ကုဋေ
-၄.၄၁ ကုဋေ
-၄.၁၀ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ